Scarica l'app Stockscreener
11.80
0.08%
0.01
Dopo l'orario di chiusura:
11.79
-0.01
-0.08%
Precedente Chiudi:
$11.79
Aprire:
$11.67
Volume 24 ore:
256.33K
Relative Volume:
0.63
Capitalizzazione di mercato:
$476.98M
Reddito:
$825.37M
Utile/perdita netta:
$-60.01M
Rapporto P/E:
-7.8557
EPS:
-1.5021
Flusso di cassa netto:
$-4.46M
1 W Prestazione:
+4.89%
1M Prestazione:
+29.10%
6M Prestazione:
-10.81%
1 anno Prestazione:
+6.88%
Intervallo 1D:
$11.41
$11.90
Intervallo di 1 settimana:
$11.32
$12.58
Portata 52W:
$8.85
$16.99
Orthofix Medical Inc Stock (OFIX) Company Profile
Nome
Orthofix Medical Inc
Settore
Industria
Telefono
214-937-2000
Indirizzo
3451 PLANO PARKWAY, LEWISVILLE, TX
Compare OFIX vs ABT, SYK, MDT, BSX, EW
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
OFIX
Orthofix Medical Inc
|
11.80 | 481.02M | 825.37M | -60.01M | -4.46M | -1.5021 |
ABT
Abbott Laboratories
|
105.74 | 182.00B | 46.59B | 5.41B | 7.38B | 3.0938 |
SYK
Stryker Corp
|
325.74 | 129.09B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
85.40 | 107.81B | 36.36B | 4.84B | 5.43B | 3.7261 |
BSX
Boston Scientific Corp
|
46.73 | 67.64B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
86.03 | 47.81B | 6.30B | 1.07B | 1.09B | 1.8406 |
Orthofix Medical Inc Stock (OFIX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-01-27 | Iniziato | TD Cowen | Hold |
| 2025-10-28 | Ripresa | Stifel | Buy |
| 2025-01-22 | Iniziato | Canaccord Genuity | Buy |
| 2024-11-08 | Aggiornamento | Stifel | Hold → Buy |
| 2024-05-08 | Aggiornamento | ROTH MKM | Neutral → Buy |
| 2023-10-20 | Iniziato | ROTH MKM | Neutral |
| 2023-09-12 | Downgrade | BTIG Research | Buy → Neutral |
| 2023-09-12 | Downgrade | Stifel | Buy → Hold |
| 2023-07-19 | Ripresa | BTIG Research | Buy |
| 2022-03-04 | Aggiornamento | Stifel | Hold → Buy |
| 2020-10-20 | Iniziato | Stifel | Hold |
| 2019-10-29 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| 2018-06-01 | Iniziato | Cantor Fitzgerald | Overweight |
| 2017-06-21 | Iniziato | BTIG Research | Buy |
| 2017-06-14 | Iniziato | Ladenburg Thalmann | Buy |
| 2017-05-23 | Iniziato | SunTrust | Buy |
| 2015-07-10 | Iniziato | Sidoti | Buy |
| 2013-05-09 | Downgrade | Mizuho | Buy → Neutral |
| 2013-01-08 | Reiterato | Mizuho | Buy |
| 2010-06-21 | Iniziato | Boenning & Scattergood | Outperform |
| 2010-03-09 | Reiterato | Jefferies & Co | Buy |
| 2010-02-18 | Aggiornamento | Susquehanna Financial | Neutral → Positive |
| 2010-01-22 | Iniziato | Jefferies & Co | Buy |
| 2009-11-03 | Aggiornamento | Wells Fargo | Underperform → Market Perform |
| 2009-07-31 | Reiterato | Jefferies & Co | Buy |
| 2009-07-31 | Aggiornamento | Thomas Weisel | Market Weight → Overweight |
| 2009-05-26 | Reiterato | Jefferies & Co | Buy |
| 2009-04-17 | Downgrade | Wachovia | Mkt Perform → Underperform |
| 2009-02-19 | Iniziato | Canaccord Adams | Buy |
| 2008-07-07 | Downgrade | Wachovia | Outperform → Mkt Perform |
Mostra tutto
Orthofix Medical Inc Borsa (OFIX) Ultime notizie
Can Orthofix Medical (NASDAQ:OFIX) Capitalize on A Key Medicare Shift? - Kalkine Media
OFIX|Orthofix Medical Inc|Price:11.885|Chg%:+0.635 - TradingKey
Orthofix Medical Inc (OFIX) Cash Flow - TradingKey
Orthofix Medical Inc (OFIX) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Orthofix Medical Inc (OFIX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Orthofix Medical Inc (OFIX) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
OFIX|Orthofix Medical Inc|Price:11.715|Chg%:+0.465 - TradingKey
OFIX|Orthofix Medical Inc|Price:11.460|Chg%:+0.210 - TradingKey
Orthofix Medical Inc. (OFIX) stock price, news, quote and history - Yahoo Finance UK
Orthofix Medical Inc (OFIX) Institutional Confidence - TradingKey
Orthofix Medical (OFIX) Looks Attractive After CMS Reversed Its Reimbursement - Yahoo Finance
Wall Street Analysts Think Orthofix (OFIX) Could Surge 33.28%: Read This Before Placing a Bet - Yahoo Finance Singapore
Hospitals Get Live Surgical Case Views With Canopus Command - Stock Titan
MedTech Pioneer Max Reinhardt Joins eXeX to Drive Canopus Platform Growth - Sahm
Orthofix to Participate in Upcoming Investor Conferences - Business Wire
Press Release: Orthofix to Report Second Quarter 2026 Financial Results - Moomoo
Orthofix to Report Second Quarter 2026 Financial Results - Business Wire
Orthofix surges after CMS change on non-invasive bone growth stimulators - MSN
Price to sales forward of Orthofix Medical Inc. – NASDAQ:OFIX - TradingView
Orthofix Medical (OFIX) Gets a Buy from Canaccord Genuity - The Globe and Mail
CCORF Maintains Orthofix Medical(OFIX.US) With Buy Rating, Maintains Target Price $18 - Moomoo
Orthofix Medical (OFIX) Dips 1.54% as Stock Approaches Key Support LevelGap Up Stocks - dars.gov.et
SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of Orthofix Medical Inc. (NASDAQ: OFIX) - AOL.com
Orthofix Medical | 4: Statement of changes in beneficial ownership of securities-Director Hannon Jason - Moomoo
Enterprise value to EBIT forward of Orthofix Medical Inc. – NASDAQ:OFIX - TradingView
Enterprise value to EBITDA forward of Orthofix Medical Inc. – NASDAQ:OFIX - TradingView
Did Orthofix Medical Inc. Insiders Breach their Fiduciary Duties to Shareholders? - aol.com
Price to sales forward of Orthofix Medical Inc. – BOATS:OFIX - TradingView
Orthofix Medical (OFIX) Receives a Buy from Barrington - The Globe and Mail
Price to book forward of Orthofix Medical Inc. – NASDAQ:OFIX - TradingView
Orthofix Medical | 8-K: Orthofix Reports Fourth Quarter and Full-Year 2025 Financial Results and Provides 2026 Financial Guidancemoomoo - Moomoo
Orthofix Medical Shares Rise After Medicare Billing for Bone Growth Stimulators Expected to Return to Prior Rates - Moomoo
Orthofix Medical (OFIX) Soars 16% Following CMS Reversal on Bone Growth Stimulators - GuruFocus
Canaccord reiterates Orthofix Medical stock rating after CMS reversal - Investing.com
Canaccord reiterates Orthofix Medical stock rating after CMS reversal By Investing.com - Investing.com Nigeria
Orthofix Medical Is Maintained at Outperform by Barrington Research - Moomoo
Why is Orthofix Medical stock surging today? By Investing.com - Investing.com Canada
Orthofix Medical stock surges on Medicare reimbursement reversal By Investing.com - Investing.com Australia
Orthofix Medical stock surges on Medicare reimbursement reversal - Investing.com
Orthofix (OFIX) Adjusts Expectations After Medicare Guidance Cha - GuruFocus
Orthofix Medical Inc. (OFIX) Sees 6.7% Pre-Market Increase - GuruFocus
Enterprise value to revenue forward of Orthofix Medical Inc. – NASDAQ:OFIX - TradingView
Orthofix Medical rises on CMS reversal of non-invasive bone growth stimulators - MSN
SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Orthofix - TMX Newsfile
Orthofix Medical Sees Medicare Reimbursement Policy Restored - The Globe and Mail
Orthofix Medical (OFIX) Among the Best Small-Cap Growth Stocks To Buy Now - Yahoo Finance
Orthofix Medical (OFIX) Surges 10% After CMS Reversal on Bone Gr - GuruFocus
Orthofix (OFIX) expects Medicare bone stimulator reimbursement to return to prior levels - Stock Titan
Orthofix (OFIX) moves 5.1% higher: Will this strength last? - MSN
Orthofix (OFIX) Moves 5.1% Higher: Will This Strength Last? - Yahoo Finance
Why (OFIX) Price Action Is Critical for Tactical Trading - Stock Traders Daily
Orthofix Medical Inc Azioni (OFIX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Orthofix Medical Inc Azioni (OFIX) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| HENNEMAN JOHN B III | Director |
May 07 '26 |
Buy |
12.26 |
5,000 |
61,295 |
90,809 |
| Engine Capital Management, LP | 10% Owner |
May 05 '26 |
Buy |
11.99 |
112,950 |
1,354,587 |
3,783,131 |
| Engine Capital Management, LP | 10% Owner |
May 06 '26 |
Buy |
12.23 |
41,946 |
512,916 |
3,821,285 |
| Engine Capital Management, LP | 10% Owner |
May 07 '26 |
Buy |
12.18 |
30,000 |
365,425 |
3,848,573 |
| Cedron Jorge Andres | CLO |
Apr 16 '26 |
Sale |
12.82 |
3,743 |
47,985 |
59,006 |
| Vitale Lucas | CP&BOO |
Mar 17 '26 |
Sale |
11.92 |
4,269 |
50,886 |
160,449 |
| CAPPS VICKIE L | Director |
Mar 09 '26 |
Buy |
12.48 |
2,500 |
31,200 |
25,085 |
| CAPPS VICKIE L | Director |
Mar 10 '26 |
Buy |
12.45 |
2,500 |
31,124 |
27,585 |
| Andrews Julie | CFO |
Mar 04 '26 |
Sale |
12.92 |
2,425 |
31,322 |
91,109 |
| Andrews Julie | CFO |
Mar 05 '26 |
Sale |
12.55 |
2,363 |
29,658 |
88,746 |
1.04%
11.95%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):